Amaroq Therapeutics
PrivateLast Round
Seed
Jul 8, 2021
Total Funding Raised
$9.7M
Company Overview
Amaroq Therapeutics operates in Healthcare & Life Sciences and is based in Dunedin. Its latest recorded funding round was a Seed round in July 2021.
Amaroq Therapeutics is a biotechnology company that develops cancer therapeutics targeting long non-coding RNA.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amaroq Therapeutics Comparables
Compare Amaroq Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Flamingo Therapeutics | 88% | |
| NextRNA Therapeutics | 86% | |
| 水木星辰生物制药(深圳)有限公司 | 81% |
For institutional investors. Book with your work email.
Amaroq Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Amaroq Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Otago Innovation Ltd | Seed |
| Cure Kids Ventures | Seed |
| Booster | Seed |
| Brandon Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 29, 2024
Monthly visitors increased 45% MoM.
- Jul 8, 2021
$9.7M round led by Brandon Capital
For institutional investors. Book with your work email.
Amaroq Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Amaroq Therapeutics's valuation, stock price, and market status.
Is Amaroq Therapeutics a public or private company?
Amaroq Therapeutics is a private company.
What is the current stock price of Amaroq Therapeutics?
Amaroq Therapeutics is a private company, so its shares have no public market price. Caplight tracks Amaroq Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Amaroq Therapeutics worth (valuation)?
Valuation information for Amaroq Therapeutics is not publicly available.
Can I buy Amaroq Therapeutics stock?
Amaroq Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Amaroq Therapeutics's last funding round?
Amaroq Therapeutics's most recent funding round was Seed on July 8, 2021.
Who are the main investors in Amaroq Therapeutics?
Key investors in Amaroq Therapeutics include Otago Innovation Ltd, Cure Kids Ventures, Booster, Brandon Capital.
Will Amaroq Therapeutics IPO soon?
No public IPO plans have been announced for Amaroq Therapeutics.
How can I track Amaroq Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Amaroq Therapeutics's shares on secondary markets.